Market Expansion Zentiva's broad portfolio across key therapeutic areas such as Cardiology, Diabetes, Oncology, Respiratory, and CNS, combined with its focus on self-care products, presents numerous opportunities to introduce complementary healthcare solutions and expand product lines within the European market.

Acquisition Opportunities Recent acquisitions of heritage brands and partnership with Cinclus Pharma highlight Zentiva's openness to strategic M&A and licensing collaborations, offering potential avenues for joint ventures or co-marketing initiatives targeting natural-based and cardiovascular product segments.

Sustainability Credibility Winning the ESG Transparency Award 2025 demonstrates Zentiva's commitment to sustainability and corporate responsibility, which can be leveraged to position new products to environmentally conscious healthcare providers and consumers.

Supply Chain Stability With four wholly owned manufacturing sites and a network of external partners, Zentiva emphasizes supply security—a critical selling point for hospitals and pharmacy chains seeking reliable medication sources amid global supply chain uncertainties.

Growth Potential Ambitious plans for sustained double-digit growth and recent high-profile acquisitions suggest a strong momentum for organic and inorganic expansion, creating opportunities to offer innovative developments or support services aligned with Zentiva's strategic growth initiatives.